|
E-Newsletter • October 2022 |
▼ ADVERTISEMENT
Editor's E-Note
Breast cancer screening is a proven method of reducing breast cancer deaths. Unfortunately, access to screening varies. For Breast Cancer Awareness month, we’re highlighting a study that sheds light on disparities in breast screening and offers suggestions for how to make it more widely accessible.
What’s the availability of breast screening in your community? Let us know what you think about it on Twitter and/or Facebook.
— Dave Yeager, editor |
|
|
|
▼ ADVERTISEMENT
 |
▼ ADVERTISEMENT
Study Finds Racial Disparities in Access to New Mammography Technology
Among the Medicare population from 2005 to 2020, Black women had less access to new mammography technology compared with white women, even when getting their mammograms at the same institution, according to a study of more than 4 million claims published in Radiology, a journal of RSNA. Black women are 40% more likely than white women to die from breast cancer, although the cancer incidence rate among Black and white women is approximately the same.
Mammographic technology used to screen for breast cancer has undergone two major transitions since 2000: First, the transition from screen-film mammography to full-field digital mammography and second, the transition to digital breast tomosynthesis (DBT). While these advances in early detection mean that more women can survive breast cancer, not all women have equal access to these newer technologies.
More sufficient, initial Medicare coverage can aid access to new breast cancer screening technologies in underserved areas and reduce the duration of related racial and regional breast cancer care disparities. Such disparities are transitory and eventually ease as technology dissipates from affluent areas (with more private insurance coverage) to underserved communities where public insurance may be more prevalent. However, this process is prolonged by Medicare reimbursement that is 1.2 to 1.8 times lower than that of private insurers.
▼ ADVERTISEMENT
 |
AI-Based Imaging Solution Produces Results With Astounding Accuracy
Lunit, an AI software development company, has released a study in collaboration with the University of Edinburgh’s Queen’s Medical Research Institute Medical Research Institute that found its AI-based imaging tool has the accuracy of professional radiologists.
Low-Field MRI Identifies Lingering COVID-19 Manifestations in Children
A study published in Radiology revealed that low-field MRI may be useful in identifying any persistent pulmonary manifestations post COVID-19 infection in children.
Study Finds High Magnetic Field Disrupts Side Effects of Anticancer Drug
The study, published in the European Journal of Nuclear Medicine and Molecular Imaging revealed that combining imatinib, an anticancer drug, and a static magnetic field enhanced the drug’s cancer fighting effects and reduced negative side effects in mice.
German Health Care System Moves to Improve Workflow and Patient Outcomes
Germany’s ANregiomed health care system is adopting the radiology module of Sectra, a medical imaging IT and cybersecurity company, which boasts improved radiology workflows, enhanced reporting, and ease of information and resource sharing.
▼ ADVERTISEMENT
 |
“Access to an interventional radiologist’s care can be the difference between life and death, yet millions of Americans living in rural communities do not have access to the image-guided treatments interventional radiologists perform to literally save life and limb. Access to IR services improves the care offered within a hospital or health system. The recommendations outlined in this paper will help practices attract IR talent and expand IR services where they are often needed the most, eliminating IR deserts and improving patients’ access to the care they need.”
|
|
|
COVER STORY
A Matter of Access
Access to quality, local mammography centers is a hindrance to care in underserved communities. Hospitals and mammography centers are bridging these gaps by bringing equipment to communities.
FEATURE
Search and Destroy
A new treatment for prostate cancer offers promising results in destroying cancer cells and minimizing harm to normal cells.
|
|
|
| Advertising Opportunities |
Have a product or service you want to market to radiology professionals? Utilize the reach of Radiology Today Magazine to accomplish your marketing goals. Email our experienced account executives today at sales@gvpub.com or call 800-278-4400 for more information.
|
| © 2022 Radiology Today Magazine |
|
|
